|
Fund Size
(2.74% of Investment in Category)
|
Expense Ratio
(0.63% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 17-Nov-25 | 9815.70 | -1.84% | - | -1.50% | 28/33 |
| 1 Month | 24-Oct-25 | 9985.70 | -0.14% | - | -0.41% | 12/32 |
| 3 Month | 22-Aug-25 | 10205.00 | 2.05% | - | 1.69% | 16/33 |
| 6 Month | 23-May-25 | 10574.10 | 5.74% | - | 5.42% | 18/32 |
| YTD | 01-Jan-25 | 10354.00 | 3.54% | - | 3.20% | 14/30 |
| 1 Year | 22-Nov-24 | 10761.50 | 7.62% | 7.57% | 5.92% | 9/29 |
| 2 Year | 24-Nov-23 | 14046.10 | 40.46% | 18.49% | 18.33% | 13/24 |
| 3 Year | 24-Nov-22 | 17551.00 | 75.51% | 20.60% | 19.74% | 6/16 |
| 5 Year | 24-Nov-20 | 30161.10 | 201.61% | 24.69% | 22.22% | 2/9 |
| Since Inception | 11-May-17 | 41816.00 | 318.16% | 18.23% | 15.81% | 12/31 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 22-Nov-24 | 12000 | 12748.48 | 6.24 % | 11.68 % |
| 2 Year | 24-Nov-23 | 24000 | 26641.25 | 11.01 % | 10.36 % |
| 3 Year | 24-Nov-22 | 36000 | 47053.13 | 30.7 % | 18.15 % |
| 5 Year | 24-Nov-20 | 60000 | 98492.98 | 64.15 % | 19.89 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 1920.3 | 3.17% | 0.14% | 3.66% (Feb 2025) | 2.97% (Nov 2024) | 2.85 L | -0.20 L |
| ICICI Bank Ltd. | Private sector bank | 1887.5 | 3.12% | -0.19% | 3.63% (Jul 2025) | 1.71% (Jun 2025) | 14.03 L | 0.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1870.4 | 3.09% | -0.29% | 3.48% (Jul 2025) | 0% (Nov 2024) | 9.89 L | 0.00 |
| Indus Towers Ltd. | Telecom - infrastructure | 1632.6 | 2.70% | 0.01% | 3.6% (Apr 2025) | 0% (Nov 2024) | 44.90 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1498.8 | 2.48% | 0.89% | 2.48% (Oct 2025) | 0% (Nov 2024) | 14.65 L | 5.30 L |
| Ultratech Cement Ltd. | Cement & cement products | 1493.4 | 2.47% | -0.20% | 2.81% (Aug 2025) | 0% (Nov 2024) | 1.25 L | 0.00 |
| Angel One Ltd. | Stockbroking & allied | 1487.2 | 2.46% | 0.95% | 2.46% (Oct 2025) | 0.83% (Feb 2025) | 5.97 L | 1.93 L |
| - Polycab India Limited | Cables - electricals | 1486.9 | 2.46% | 0.00% | 2.46% (Oct 2025) | 0% (Nov 2024) | 1.93 L | 0.00 |
| State Bank Of India | Public sector bank | 1457 | 2.41% | 0.42% | 2.41% (Oct 2025) | 0% (Nov 2024) | 15.55 L | 2.50 L |
| J S W Steel Ltd. | Iron & steel products | 1445.1 | 2.39% | 0.96% | 2.39% (Oct 2025) | 0% (Nov 2024) | 11.98 L | 4.80 L |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.85% |
| Net Receivables | Net Receivables | 0.11% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Motilal Oswal Multi Cap Fund - Direct Plan - Growth | NA | 4603.13 | -0.10 | 0.73 | 5.17 | 11.13 | 0.00 |
| WhiteOak Capital Multi Cap Fund - Direct Plan - Growth | NA | 2638.72 | 1.07 | 3.52 | 9.43 | 10.39 | 0.00 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4388.81 | -0.09 | 3.21 | 7.77 | 9.50 | 0.00 |
| Kotak Multicap Fund - Direct Plan - Growth | 4 | 21541.46 | 0.73 | 5.40 | 9.80 | 7.70 | 24.62 |
| Franklin India Multi Cap Fund - Direct Plan - Growth | NA | 5128.67 | 0.47 | 3.17 | 7.84 | 7.65 | 0.00 |
| PGIM India Multi Cap Fund - Direct Plan - Growth | NA | 434.64 | -1.26 | 1.29 | 7.47 | 7.47 | 0.00 |
| Canara Robeco Multi Cap Fund - Direct Plan - Growth | NA | 4902.07 | 0.20 | 1.79 | 6.53 | 6.31 | 0.00 |
| Sundaram Multi Cap Fund - Direct Plan - Growth | 3 | 2927.98 | -0.83 | 2.04 | 6.38 | 6.01 | 18.28 |
| SBI Multicap Fund - Direct Plan - Growth | 3 | 23986.25 | -1.82 | -0.10 | 3.46 | 5.77 | 17.56 |
| Union Multicap Fund - Direct Plan - Growth | NA | 1335.77 | -0.06 | 2.55 | 7.58 | 5.63 | 0.00 |
Out of 25 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 2 is/are ranked 4 * , 6 is/are ranked 3 * , 1 is/are ranked 2 * , 3 is/are ranked 1 * , and 12 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mahindra Manulife Multi Cap Fund - Direct Plan - Growth | 3 | 6055.38 | -0.14 | 2.05 | 5.74 | 7.57 | 20.60 |
| Mahindra Manulife Small Cap Fund - Direct Plan - Growth | NA | 4307.53 | -1.88 | 0.85 | 6.38 | 1.97 | 0.00 |
| Mahindra Manulife Mid Cap Fund - Direct Plan - Growth | 3 | 4192.44 | 0.46 | 2.26 | 4.70 | 4.48 | 25.43 |
| Mahindra Manulife Large & Mid Cap Fund - Direct Plan - Growth | 1 | 2783.80 | -0.51 | 2.25 | 4.66 | 5.15 | 17.46 |
| Mahindra Manulife Focused Fund - Direct Plan - Growth | 4 | 2207.79 | 0.23 | 4.17 | 4.67 | 7.28 | 19.90 |
| Mahindra Manulife Aggressive Hybrid Fund - Direct Plan - Growth | 5 | 1969.84 | 0.21 | 2.35 | 4.46 | 9.27 | 18.00 |
| Mahindra Manulife Flexi Cap Fund - Direct Plan - Growth | 4 | 1575.38 | -0.10 | 2.85 | 4.62 | 8.48 | 18.02 |
| Mahindra Manulife Business Cycle Fund - Direct Plan - Growth | NA | 1285.41 | 0.85 | 5.56 | 6.59 | 7.74 | 0.00 |
| Mahindra Manulife Liquid Fund - Direct Plan - Growth | 1 | 1044.57 | 0.50 | 1.47 | 3.02 | 6.73 | 7.11 |
| Mahindra Manulife ELSS Tax Saver Fund - Direct Plan - Growth | 3 | 970.35 | -0.08 | 2.55 | 4.21 | 8.90 | 15.86 |